Fibroblast Derived from Vaginal Tissue Evaluation

Overview

About this study

The purpose of this study is to evaluate the effectiveness of different methods of culturing vaginal fibroblasts, and to test different biomarkers and probes on the vaginal fibroblasts.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Age 18 years or older.
Biologically female.
Present to the Mayo Clinic Gynecology Department in Florida and who are planning on undergoing vaginal and/or laparoscopic surgery.

Exclusion Criteria:

Congenital genitourinary abnormality (e.g., Mullerian agenesis).

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 7/21/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Jacksonville, Fla. Mayo Clinic principal investigator Olivia Cardenas-Trowers, M.D.	Open for enrollment	Contact information: Clinical Studies Unit (904) 953-2255

Mayo Clinic Location

Status

Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Olivia Cardenas-Trowers, M.D.

Open for enrollment

Contact information:

Clinical Studies Unit

(904) 953-2255

More information

Publications

Publications are currently not available

Clinical Trials